💉 Sanofi latest to cut insulin prices; AstraZeneca India tries to cut workforce; Novo Nordisk UK cut from pharma association

#299 | No limit to European cow burps; No security for India’s health data; No safe drinking water for billions

Hello and welcome to the end of another week with The Kable. Our exclusive to Friday section, The Week That Was, has all the developments that made the past five days feel so incredibly long. And then a bunch more for you today.

Best things first, Sanofi is following in the footsteps of Eli Lilly and Novo Nordisk, slashing its insulin prices by 78% start…